Microviable Therapeutics will be presenting at AIMID 2022 Meeting

2022-09-16T11:00:49+02:0016 de September de 2022|

Microviable Therapeutics will be presenting at I Asturias International Meeting on Clinical Microbiology and Infectious Disease (AIMID 2022) on September 22-23. Claudio Hidalgo, CEO at Microviable, will discuss the use of “Microbiome-derived biotherapeutic products for [...]